PERMIT

• Research type

  Research Study

• Full title

  PROSPECTIVE EVALUATION OF RADIOTHERAPY USING MAGNETIC RESONANCE IMAGE GUIDED TREATMENT (PERMIT)

• IRAS ID

  236188

• Contact name

  Robert Huddart

• Contact email

  robert.huddart@icr.ac.uk

• Sponsor organisation

  Institute of Cancer Research

• Duration of Study in the UK

  4 years, 9 months, 27 days

• Research summary

  The purpose of PERMIT is to collect information on the treatment of radiotherapy patients using a new radiotherapy machine that includes Magnetic Resonance (MR) imaging (MR linac) to guide treatment. The aim is to use this infomation to support the introduction of MR Linac into clinical practice.
  
  PERMIT will collect details on patients treated on the MR linac plus details on their side effects and other outcomes. This information plus technical and imaging information will be combined with information from other centres using this machine. By doing so this will help us learn how best to use the MR Linac in the future and design new radiotherapy protocols.

• REC name

  West of Scotland REC 5

• REC reference

  18/WS/0174

• Date of REC Opinion

  27 Sep 2018

• REC opinion

  Favourable Opinion